TRI-SPRINTEC
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
Molecular Identity
TRI-SPRINTEC
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
PubChem CID: 9571023
2D Structure
Properties
C43H55NO5
Molecular Formula
665.90
Molecular Weight
g/mol
665.4080
Exact Mass
Da
99.4
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
6
H-Bond Acceptors
1250
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
TRI-SPRINTECTricilesteOrtho Tri-CyclenPraminoPrevifemSprintecTricilestTri prevofemTri-previfemOrtho CylenTri CyclenOrtho Tri-CylenOrtho Tri LoTriNessa-28Cilest
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to TRI-SPRINTEC
Loading drug network...